Heimdall Insights

Global Hypertrophic Cardiomyopathy Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Hypertrophic Cardiomyopathy Market was valued at $2.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 3.6% CAGR, to an estimated market size of $2.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global hypertrophic cardiomyopathy (HCM) market encompasses the diagnostic tools, pharmacological treatments, and medical devices used to manage the abnormal thickening of the heart muscle. The scope includes cardiac myosin inhibitors, beta-blockers, and calcium channel blockers, as well as implantable cardioverter-defibrillators (ICDs) and pacemakers, while excluding general cardiovascular care not specific to HCM pathology.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Hypertrophic Cardiomyopathy Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Obstructive HCM
  • Non-obstructive HCM